The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Substandard medicines in resource‐poor settings: a problem that can no longer be ignored
Open accessAbstract
Summary: The circulation of substandard medicines in the developing world is a serious clinical and public health concern. Problems include under or over concentration of ingredients, contamination, poor quality ingredients, poor stability and inadequate packaging. There are multiple causes. Drugs manufactured for export are not regulated to the same standard as those for domestic use, while regulatory agencies in the less‐developed world are poorly equipped to assess and address the problem. A number of recent initiatives have been established to address the problem, most notably the WHO pre‐qualification programme. However, much more action is required. Donors should encourage their partners to include more explicit quality requirements in their tender mechanisms, while purchasers should insist that producers and distributors supply drugs that comply with international quality standards. Governments in rich countries should not tolerate the export of substandard pharmaceutical products to poor countries, while developing country governments should improve their ability to detect substandard medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO technical report series 200 (1960).
Pittman, M. (1974) · PubMed · Cited by 1,448
Counterfeit anti-infective drugs
Newton, P. N., Green, M. D., Fernández, F. M., Day, N. P., & White, N. J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70581-3 · Cited by 348
(2006) · Technical Report Series 936 · doi:10.2471/trs.06.930 · Cited by 347
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence
Kelesidis, T., Kelesidis, I., Rafailidis, P. I., & Falagas, M. E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm109 · Cited by 242
Assessment of the incidence of substandard drugs in developing countries
Shakoor, O., Taylor, R. B., & Behrens, R. H. (1997) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1997.d01-403.x · Cited by 228
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies
Taylor, R., Shakoor, O., Behrens, R., Everard, M., Low, A., Wangboonskul, J., Reid, R., & Kolawole, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05065-0 · Cited by 221
Newton, P. N., Fernández, F. M., Plançon, A., Mildenhall, D. C., Green, M. D., Ziyong, L., Christophel, E. M., Phanouvong, S., Howells, S., McIntosh, E., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050032 · Cited by 216
Epidemic of Pediatric Deaths From Acute Renal Failure Caused by Diethylene Glycol Poisoning
O'Brien, K. L. (1998) · JAMA · doi:10.1001/jama.279.15.1175 · Cited by 205
Under‐reporting of adverse drug reactions in general practice
Moride, Y., Haramburu, F., Requejo, A. A., & Bégaud, B. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.05417.x · Cited by 201
Schep, L. J., Slaughter, R. J., Temple, W. A., & Beasley, D. M. G. (2009) · Clinical Toxicology · doi:10.1080/15563650903086444 · Cited by 192
Cited by
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-15 · Cited by 1,156
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Essential medicines for universal health coverage
Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31599-9 · Cited by 661
Edmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631
Ozawa, S., Evans, D. R., Bessias, S., Haynie, D. G., Yemeke, T. T., Laing, S. K., & Herrington, J. E. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1662 · Cited by 356
Metadata
- Authors
- Caudron, J. ‐., Ford, N., Henkens, M., Macé, C., Kiddle‐Monroe, R., & Pinel, J.
- Venue
- Tropical Medicine & International Health
- Publisher
- Wiley
- Published
- 2008-07-28
- Volume
- 13
- Issue
- 8
- Pages
- 1062-1072
- ISSN
- 1360-2276 (ISSN-L)
- 1365-3156
- OpenAlex
- W1969400171
- Cited by
- 332
- References
- 24
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Substandard medicines in resource‐poor settings: a problem that can no longer be ignored. https://app.cochat.ai/papers/10.1111/j.1365-3156.2008.02106.x
- The paper
- Caudron, J. ‐., Ford, N., Henkens, M., Macé, C., Kiddle‐Monroe, R., & Pinel, J. (2008). Substandard medicines in resource‐poor settings: a problem that can no longer be ignored. Tropical Medicine & International Health. https://doi.org/10.1111/j.1365-3156.2008.02106.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
